Severe thrombocytopenia during treatment with valproate;Schwere thrombozytopenie unter valproattherapie

Monatsschrift fur Kinderheilkunde

Volumn 150, Issue 10, 2002, Pages 1208-1213

  Heuberger, A ^a   Dempfle, C E ^b   Teich, M ^a   Koelfen, W ^a   Konig S A ^a  

^a Universitätskinderklinik Mannheim ^*  (Germany)

^b UNIVERSITY OF MANNHEIM   (Germany)

Author keywords

Coagulation disorder; Spontaneous bleeding; Thrombocytopenia; Valproic acid

Indexed keywords

BLOOD CLOTTING FACTOR 13; VALPROIC ACID; VIGABATRIN;

ARTICLE; BLEEDING; BLOOD CLOTTING DISORDER; BLOOD CLOTTING TEST; CASE REPORT; EPILEPSY; HUMAN; MALE; PERIPHERAL EDEMA; SCHOOL CHILD; SEIZURE; THROMBOCYTOPENIA;

EID: 0036939682     PISSN: 00269298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00112-001-0350-6     Document Type: Article

References (36)

1. Anderson GD, Lin YX, Berge C, Ojemann GA (1997) Absence of bleeding complications in patients undergoing cortical surgery while receiving valproate treatment. J Neurosurg 87: 252-256
2. Andrassy K, Berthold H, Ritz E (1985) Hypothrombinemia caused by cephalosporines. J Antimicrob Chemother 15: 133
3. Bohan TP, Helton E, McDonald I, König S, Gazitt S, Sugimoto T, Scheffner D, Cusmano L, Li S, Koch G (2001) Effect of L-carnitine treatment for valproate-induced hepatotoxicity. Neurology 56: 1405-1409
4. Brichard B, Vermylen C, Scheff JM, Ninane J, Cornu G (1994) Haematological disturbances during long-term valproate therapy. Eur J Pediatr 153: 378-380
5. Chambers HG, Weinstein CH, Mubarak SJ, Wenger Dr, Silvia PD (1999) The effect of valproic acid on blood loss in patients with cerebral palsy. J Pediatr Orthop 19: 792-795
6. Chattergoon DS, McGuigan MA, Koren G, Hwang P, Ito S (1997) Multiorgan dysfunction and disseminated intravascular coagulation in children receiving lamotrigene and valproic acid. Neurology 49: 1442-1444
7. Cheng RD, Kohrman MH, Kerr SL, Duffner PK, Cohen ME (1989) Thrombocytopenia associated with valproic acid that requires platelet transfusion. Ann Neurol 26: 457-458
8. Davis LL, Ryan W, Adinoff B, Petty F (2000) Comprehensive review of the psychiatric uses of valproate. J Clin Psychopharmacol [Suppl 1] 20: 1S-17S
9. Delgado MR, Riela AR, Mills J, Browne R, Roach ES (1994) Thrombocytopenia secondary to high valproate levels in children with epilepsy. J Child Neurol 9: 311-314
10. Diener HC, Kaube H, Limmroth V (1999) Antimigraine drugs. J Neurol 246: 515-519
11. Dorothy J, Ganick MD, Theodore Sunder MD, James L, Finley MD (1990) Severe hematologic toxicity of valproic acid. Am J Pediatr Hematol Oncol 12: 80-95
12. Dreifuss FE, Langer DH, Moline KA, Maxwell JE (1989) Valproic acid hepatic fatalities. II. US experience since 1984. Neurology 39: 201-207
13. Driever PH, Knupfer MM, Cinatl J, Wolff JE (1999) Valproic acid for the treatment of pediatric malignant glioma. Klin Padiatr 211: 323-328
14. Ganick DJ, Sunder T, Finley JL (1990) Severe hematologic toxicity of valproic acid. A report of four patients. Am J Pediatr Hematol Oncol 12: 80-85
15. Hauser E, Seidl R, Freilinger M, Male C, Herkner K (1996) Hematologic manifestations and impaired liver synthetic function during valproate monotherapy. Brain Dev 18: 10S-109
16. Hull RL, Brandon D (1991) Thrombocytopenia possibly caused by structurally related third-generation cephalosporins. DICP 25: 135-136
17. John E, Tetzlaff MD (1991) Intraoperative defect in haemostasis in a child receiving valproic acid. Can J Anaesth 38: 222-224
18. Karges HE, Clemens R (1988) Factor XIII: enzymatic and clinical aspects. Behring Inst Mitt 82: 43-58
19. Kishi T, Fujita N, Kawaguchi H, Ishimae M, Watanabe K, Tanaka T (1994) Bone marrow suppression induced by high dose valproic acid. Arch Dis Child 71: 153-155
20. König SA, Siemes H, Bläker F, Boenigk E, Groß-Selbeck G, Hanefeld F, Haas N, Köhler B, Koelfen W, Korinthenberg R, Kurek E, Lenard HG, Penin H, Penzien JM, Schönke W, Schultze C, Stephani U, Stute A, Traus M, Weinmann HM, Scheffner D (1994) Severe side effects in children with valproate therapy. An update and report of 8 new fatalities. Epilepsia 35: 1005-1015
21. König SA, Elger CE, Vassella F, Schmidt D, Bergmann A, Boenigk HE, Despland PA, Genton P, Kramer G, Loscher W, Mayer T, Nau H, Schneble H, Siemes H, Wolf P (1998) Recommendations for blood studies and clinical monitoring in early detection of valproate-associated liver failure. Results of a consensus conference 9 May-11 May 1997 in Berlin. Nervenarzt 69: 835-840
22. Kreuz W, Linde R, Funk M, Meyer-Schrod R, Foll E, Nowak-Gottl U, Jacobi G, Vigh Z, Scharrer I (1992) Valproate therapy induces von Willebrand disease type I. Epilepsia 33: 178-184
23. Monnet P, David M, Philippe N, Dechavanne M, Floret D, Renaud H, Trezeciak MC, Brazier JL, Bourdillon D (1979) Alterations de l'hemostase lors des traitments au dipropylacetate de sodium (Depakine). Pediatrie 34: 603-620
24. Raymond G, Watts MD, Peter D, Emanuel MD, Kenneth S, Zuckerman MD, Thomas H, Howard MD (1990) Valproic acid-induced cytopenias: evidence for a dose-related suppression of haematopoiesis. J Pediatr 117: 495-499
25. Sandler RM, Emberson C, Roberts GE, Voak D, Darnborough J, Heeley AF (1978) IgM platelet autoantibody due to sodium valproate. BMJ 2: 1683-1684
26. Sleiman C, Raffy O, Roue C, Mal H (2000) Fatal pulmonary hemorrhage during high-dose valproate monotherapy. Chest 117: 613
27. Smith FR, Boots M (1980) Sodium valproate and bone marrow suppression. Ann Neurol 8: 197-199
28. Stahl MMS, Neiderud J, Vinge E (1997) Thrombocytopenic purpura and anemia in a breast-fed infant whose mother was treated with valproic acid. J Pediatr 130: 1001-1003
29. Sutor AH, Jesdinsky-Buscher (1975) Veränderungen der Hämostase bei Epilepsie-Behandlung mit Dipropylessigsäure. Fortschr Med 6: 411-414
30. Sutor AH, Jesdinsky-Buscher C (1976) Veränderungen der Hämostase bei Epilepsie-Behandlung mit Dipropylessigsäure: erweiterte Untersuchung. Fortschr Med 94: 411-414
31. Teich M, Loff St, König S (2000) Valproat-induziertes von-Willebrand Syndrom: perioperatives Management. Neuropediatrics 31: A7
32. Tetzlaff JE (1991) Intraoperative defect in haemostasis in a child receiving valproic acid. Can J Anaesth 38: 222-224
33. Ward MM, Barbaro NM, Laxer KD, Rampil IJ (1996) Preoperative valproate administration does not increase blood loss during temporal lobectomy. Epilepsia 37: 98-101
34. Ware S, Millward-Sadler GH (1980) Acute liver disease associated with sodium valproate. Lancet 22: 1110-1113
35. Winter SL, Kriel RL, Novacheck TF, Luxenberg MG, Leutgeb VJ, Erickson PA (1996) Perioperative blood loss: the effect of valproate. Pediatr Neurol 15: 19-21
36. Zeller JA, Schlessinger S, Runge U, Kessler C (1999) Influence of valproate monotherapy on platelet activation and hematologic values. Epilepsia 40: 186-189